XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.23.3

Equity Method and Other Investments Equity Method and Other Investments (Details) - USD ($) $ in Thousands | Apr. 01, 2023 | Sep. 30, 2023 | Dec. 31, 2022
--- | --- | --- | ---
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Equity method and other investments |  | $ 565,394 | $ 231,108
Mozarc Medical Holdings LLC |  |  |
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Transaction Agreement Date | May 25, 2022 |  |
Transaction Agreement Effective Closing Date | Apr. 01, 2023 |  |
Payments to Medtronic | $ 44,651 |  |
Maximum Additional Consideration to be paid between 2024 through 2028 | 300,000 |  |
Contributed Other Non-Cash Assets | 14,000 |  |
Fair value of Contingent Consideration payable to Medtronic | 86,200 |  |
Additional Cash Contributed | 224,415 |  |
Equity Method Investment, Initial Aggregate Cost | $ 375,326 |  |
Mozarc Medical Holdings LLC |  |  |
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Equity method and other investments |  | 342,315 |
Voting Equity Interest in Mozarc, Owned by Medtronic | 50.00% |  |
Voting Equity Interest by the Company | 50.00% |  |
APAC joint venture |  |  |
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Equity method and other investments |  | 98,215 | 99,141
Adjusted cost method and other investments |  |  |
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Equity method and other investments |  | 12,559 | 15,564
Other equity method partnerships |  |  |
Schedule of Equity Method and Other Investments [Line Items] |  |  |
Equity method and other investments |  | $ 112,305 | $ 116,403

X
- Definition Additional Cash Commitment + References No definition available. + Details
Name: | dva_AdditionalCashCommitment
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Agreement Date, in YYYY-MM-DD formate + References No definition available. + Details
Name: | dva_BusinessAgreementDate
Namespace Prefix: | dva_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Agreement Effective Closing Date + References No definition available. + Details
Name: | dva_BusinessAgreementEffectiveClosingDate
Namespace Prefix: | dva_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contributed Other Non-Cash Assets + References No definition available. + Details
Name: | dva_ContributedOtherNonCashAssets
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair Value Payable Of Contingent Consideration + References No definition available. + Details
Name: | dva_FairValuePayableOfContingentConsideration
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payments to Medtronic + References No definition available. + Details
Name: | dva_PaymentsToMedtronic
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This element represents the aggregate cost of investments accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_EquityMethodInvestmentAggregateCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References No definition available. + Details
Name: | us-gaap_OtherCommitmentDueInNextTwelveMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=dva_AgreementWithMedtronicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |